7Baggers
 biomea fusion (bmea) unveils promising diabetes therapy data  GuruFocus Tue, 16 Sep 2025 11:56:10 GMT
 Biomea stock sinks 16% after Phase 2 data release  MSN Tue, 16 Sep 2025 07:57:58 GMT
 this biomea fusion insider increased their holding by 200% last year  Yahoo Finance Thu, 11 Sep 2025 07:00:00 GMT
 biomea fusion, inc. $bmea shares sold by walleye capital llc  MarketBeat Wed, 10 Sep 2025 02:47:56 GMT
 nuveen llc invests $575,000 in biomea fusion, inc. $bmea  MarketBeat Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-08-30 19:59:14  Newser Sun, 31 Aug 2025 00:59:14 GMT
 biomea fusion initiated with a buy at jefferies  TipRanks Thu, 28 Aug 2025 07:00:00 GMT
 published on: 2025-08-27 13:55:18  Newser Wed, 27 Aug 2025 18:55:18 GMT
 published on: 2025-08-26 15:11:05  Newser Tue, 26 Aug 2025 20:11:05 GMT
 biomea fusion files $300m mixed securities shelf  MSN Mon, 25 Aug 2025 22:19:40 GMT
 published on: 2025-08-23 19:33:06  Newser Sun, 24 Aug 2025 00:33:06 GMT

Biomea Fusion, Inc.
(NASDAQ:BMEA) 

BMEA stock logo

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibit...

Founded: 2017
CEO: Thomas Butler  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends